Latest filing published 21 May 2026 for 지투지바이오.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -37.8%Entry ₩71,900 · Close 07 Oct 2026 ₩44,700
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
설은영: trading record in brief
This profile gathers the share dealings of 설은영 in 지투지바이오, where the filings describe the role as senior executive. We count 3 filings; the first trade dates from 6 November 2025 and the latest from 21 May 2026.
The open-market record is one-sided, with 3 purchases worth €13k and not one sale. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 2 purchases and no sales.
The latest filing, published on 21 May 2026, reports an open-market purchase in 지투지바이오. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 설은영
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,800 sharesShareKRXDART:20260521000730Canonical exit: 13 Aug 2026 (T+90)
- 300 shares@ ₩77,300.000.0032% mcap100.0% of flowShareKRXDART:20260327000302Canonical exit: 23 Jun 2026 (T+90)
- 407,310 sharesShareKRXDART:20251106000281Canonical exit: 4 Feb 2026 (T+90)
3 of 3 declarations